Evidence map›Paper›PMID 34315776›Full record

ArticleBMJ global health2021

Impact of the COVID-19 pandemic and response on the utilisation of health services in public facilities during the first wave in Kinshasa, the Democratic Republic of the Congo.

Celestin Hategeka, Simone E Carter, Faustin Mukalenge Chenge, Eric Nyambu Katanga, Grégoire Lurton, Serge Ma-Nitu Mayaka, Dieudonné Kazadi Mwamba, Esther van Kleef, Veerle Vanlerberghe, Karen Ann Grépin

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 3 pooled it
29.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 3 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 4 countries.

Celestin HategekaDepartment of Global Health and Population, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0001-7808-4652
Simone E CarterPublic Health Emergencies, UNICEF, New York, New York, USA.ORCID 0000-0003-3818-3538
Faustin Mukalenge ChengeFaculté de Médecine, Ecole de Santé Publique, Université de Lubumbashi, Lubumbashi, Democratic Republic of Congo.ORCID 0000-0001-7679-2065
Eric Nyambu KatangaMinistère de la Santé Publique de la République Démocratique du Congo, Kinshasa, Democratic Republic of Congo.
Grégoire LurtonBluesquare, Brussels, Belgium.ORCID 0000-0002-3714-6893
Serge Ma-Nitu MayakaPublic Health School of Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of Congo.ORCID 0000-0002-9124-2114
Dieudonné Kazadi MwambaPublic Health School of Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of Congo.ORCID 0000-0002-4676-2495
Esther van KleefInstitute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-3312-7185
Veerle VanlerbergheInstitute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-6531-0793
Karen Ann GrépinSchool of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong kgrepin@hku.hk.ORCID 0000-0003-4368-0045
Instituut voor Tropische Geneeskunde · BEMinistry of Public Health · CDHarvard Global Health Institute · USUnited Nations Children's Fund · USUniversity of Hong Kong · HKUniversity of Kinshasa · CDUniversity of Lubumbashi · CD

Funding

CIHR
6 · The paper itself

Abstract

introductionHealth service use among the public can decline during outbreaks and had been predicted among low and middle-income countries during the COVID-19 pandemic. In March 2020, the government of the Democratic Republic of the Congo (DRC) started implementing public health measures across Kinshasa, including strict lockdown measures in the Gombe health zone.

methodsUsing monthly time series data from the DRC Health Management Information System (January 2018 to December 2020) and interrupted time series with mixed effects segmented Poisson regression models, we evaluated the impact of the pandemic on the use of essential health services (outpatient visits, maternal health, vaccinations, visits for common infectious diseases and non-communicable diseases) during the first wave of the pandemic in Kinshasa. Analyses were stratified by age, sex, health facility and lockdown policy (ie, Gombe vs other health zones).

resultsHealth service use dropped rapidly following the start of the pandemic and ranged from 16% for visits for hypertension to 39% for visits for diabetes. However, reductions were highly concentrated in Gombe (81% decline in outpatient visits) relative to other health zones. When the lockdown was lifted, total visits and visits for infectious diseases and non-communicable diseases increased approximately twofold. Hospitals were more affected than health centres. Overall, the use of maternal health services and vaccinations was not significantly affected.

conclusionThe COVID-19 pandemic resulted in important reductions in health service utilisation in Kinshasa, particularly Gombe. Lifting of lockdown led to a rebound in the level of health service use but it remained lower than prepandemic levels.

Indexed as

COVID-19PandemicsCommunicable Disease ControlDemocratic Republic of the CongoHealth ServicesHumansPublic FacilitiesSARS-CoV-2COVID-19diseasesdisordershealth policyhealth services researchhealth systemsinfectionsinjuries

Identifiers

PMID34315776
PMCPMC8318723
OpenAlexW3186771862

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.